FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer
Relugolix is an oral form of androgen deprivation therapyFDA Approvals
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Hormones | Oral Cancer | Prostate Cancer | Urology & Nephrology